{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:09:23Z","timestamp":1790975363473,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xcrm.2026.102661","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:58:18Z","timestamp":1772866698000},"page":"102661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Tingting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangpeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenkai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chentian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiansheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naisi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6803-7438","authenticated-orcid":false,"given":"Xiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102661_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2026.102661_bib2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102661_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.xcrm.2026.102661_bib4","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1089\/thy.2018.0022","article-title":"Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer","volume":"28","author":"Sun","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.xcrm.2026.102661_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102661_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102661_bib7","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1158\/1078-0432.CCR-22-3613","article-title":"Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer","volume":"29","author":"Lin","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102661_bib8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S1470-2045(21)00332-6","article-title":"Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"22","author":"Brose","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102661_bib9","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1245\/s10434-023-14031-z","article-title":"The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study","volume":"30","author":"Chen","year":"2023","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.xcrm.2026.102661_bib10","article-title":"Response to apatinib and camrelizumab combined treatment in a radioiodine refractory differentiated thyroid cancer patient resistant to prior anti-angiogenic therapy: A case report and literature review","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102661_bib11","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1158\/1078-0432.CCR-23-3417","article-title":"Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers","volume":"30","author":"French","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102661_bib12","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-21-0124","article-title":"Diagnostic performance of next-generation sequencing and genetic profiling in thyroid nodules from a single center in China","volume":"11","author":"Ren","year":"2022","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.xcrm.2026.102661_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102661_bib14","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102661_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2967\/jnumed.119.227652","article-title":"The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer","volume":"61","author":"Liu","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.xcrm.2026.102661_bib16","doi-asserted-by":"crossref","first-page":"E1130","DOI":"10.1210\/jc.2013-4048","article-title":"TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer","volume":"99","author":"Liu","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2026.102661_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/thy.2024.0499","article-title":"High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic Outcome","volume":"35","author":"Scholfield","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.xcrm.2026.102661_bib18","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102661_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102039","article-title":"Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer","volume":"8","author":"Nannini","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.xcrm.2026.102661_bib20","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/s41467-021-26343-3","article-title":"Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma","volume":"12","author":"Pu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102661_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/ERC-19-0292","article-title":"Radioactive iodine in differentiated thyroid cancer: a national database perspective","volume":"26","author":"Orosco","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102661_bib22","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1089\/thy.2016.0650","article-title":"Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma","volume":"27","author":"Yang","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.xcrm.2026.102661_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2967\/jnumed.124.269091","article-title":"Impact of Radioactive Iodine Treatment on Long-Term Relative Survival in Patients with Papillary and Follicular Thyroid Cancer: A SEER-Based Study Covering Histologic Subtypes and Recurrence Risk Categories","volume":"66","author":"Weis","year":"2025","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.xcrm.2026.102661_bib24","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/cancers11091382","article-title":"Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies","volume":"11","author":"Aashiq","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.102661_bib25","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1210\/clinem\/dgae181","article-title":"Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life","volume":"109","author":"Marotta","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2026.102661_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1089\/thy.2024.0229","article-title":"Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [(177)Lu]Lu-DOTAGA.FAPi Dimer Therapy","volume":"35","author":"Ballal","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.xcrm.2026.102661_bib27","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/cncr.34181","article-title":"Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial","volume":"128","author":"Kiyota","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2026.102661_bib28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/RLU.0000000000000507","article-title":"Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancer","volume":"39","author":"Pitoia","year":"2014","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.xcrm.2026.102661_bib29","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1210\/jc.2006-2707","article-title":"BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism","volume":"92","author":"Durante","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2026.102661_bib30","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/clinem\/dgae271","article-title":"Genomic Landscape and Clinical Features of Advanced Thyroid Carcinoma: A National Database Study in Japan","volume":"109","author":"Toda","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2026.102661_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/clinem\/dgad697","article-title":"Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer","volume":"109","author":"Mu","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2026.102661_bib32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41421-022-00479-y","article-title":"Integrated proteogenomic characterization of medullary thyroid carcinoma","volume":"8","author":"Shi","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.xcrm.2026.102661_bib33","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1038\/s41467-025-58910-3","article-title":"Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers","volume":"16","author":"Pan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102661_bib34","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1038\/s41467-024-47926-w","article-title":"An individualized protein-based prognostic model to stratify pediatric patients with papillary thyroid carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102661_bib35","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/s41467-024-47581-1","article-title":"Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks","volume":"15","author":"Qu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102661_bib36","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/ERC-15-0533","article-title":"TERT promoter mutations in thyroid cancer","volume":"23","author":"Liu","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102661_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13046-020-01757-x","article-title":"The molecular and gene\/miRNA expression profiles of radioiodine resistant papillary thyroid cancer","volume":"39","author":"Colombo","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102661_bib38","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1038\/s41598-020-59853-z","article-title":"Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy","volume":"10","author":"Ichikawa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102661_bib39","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1541-7786.MCR-13-0358","article-title":"A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma","volume":"11","author":"Gyanchandani","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102661_bib40","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102661_bib41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102661_bib42","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf098","article-title":"Redifferentiation Effect of Larotrectinib for NTRK Fusion-Positive Pediatric Thyroid Cancer and Outcomes After Therapy","volume":"9","author":"Castellanos","year":"2025","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.xcrm.2026.102661_bib43","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2967\/jnumed.125.270055","article-title":"Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine-Refractory Metastatic Thyroid Cancer","volume":"66","author":"von Hinten","year":"2025","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.xcrm.2026.102661_bib44","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"TSH Ligand-Based CAR-T Cell Effectively Eradicates TSHR-Positive Thyroid Cancer with Favorable Safety Profile","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102661_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40164-022-00311-z","article-title":"Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer","volume":"11","author":"Ding","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2026.102661_bib46","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1158\/1078-0432.CCR-20-1523","article-title":"PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer","volume":"26","author":"Gray","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102661_bib47","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/s41596-022-00727-1","article-title":"High-throughput proteomic sample preparation using pressure cycling technology","volume":"17","author":"Cai","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.102661_bib48","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1021\/acs.jproteome.9b00790","article-title":"Accelerated Lysis and Proteolytic Digestion of Biopsy-Level Fresh-Frozen and FFPE Tissue Samples Using Pressure Cycling Technology","volume":"19","author":"Gao","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.xcrm.2026.102661_bib49","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s44321-025-00242-2","article-title":"A protein-based classifier for differentiating follicular thyroid adenoma and carcinoma","volume":"17","author":"Sun","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102661_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41421-022-00442-x","article-title":"Artificial intelligence defines protein-based classification of thyroid nodules","volume":"8","author":"Sun","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.xcrm.2026.102661_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102661_bib52","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41597-024-04322-9","article-title":"Comprehensive Mass Spectral Libraries of Human Thyroid Tissues and Cells","volume":"11","author":"Li","year":"2024","journal-title":"Sci. Data"},{"key":"10.1016\/j.xcrm.2026.102661_bib53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2105-5-160","article-title":"Reuse of imputed data in microarray analysis increases imputation efficiency","volume":"5","author":"Kim","year":"2004","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2026.102661_bib54","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102661_bib55","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.102661_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2026.102661_bib57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102661_bib58","first-page":"555","article-title":"Relationship between the initial change of Tg and outcome in differentiated thyroid carcinoma patients with pulmonary metastases after 131I treatment","volume":"37","author":"Wang","year":"2017","journal-title":"Chinese Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.xcrm.2026.102661_bib59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102661_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"10.1016\/j.xcrm.2026.102661_bib61","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102661_bib62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2026.102661_bib63","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102661_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.102661_bib65","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102661_bib66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102661_bib67","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"Hafemeister","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.102661_bib68","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2026.102661_bib69","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:22:28Z","timestamp":1783095748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126000789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666379126000789"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102661","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102661"}}